Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Val-CARD
NCT03825250Phase 2Terminated
- Sponsor
- University of Leicester
- Start
- Nov 2018
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of valproic acid in organ failure (4 arms), sponsored by University of Leicester. Primary endpoints: Change of Serum Creatinine level at 96 hours and Change of Serum Troponin I level at 72 hours. Started Nov 2018; status: terminated.
02
Drugs
valproic acid
03
Conditions
organ failure
Beyond the preview
Go deeper on NCT03825250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03825250.